---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-058018"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T15:53:04.570999+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Astrana Q1 revenue $404.4M (+20% YoY), net income $14.8M (+13%), EPS $0.31

## Summary
- Total revenue $404.4M (+20% YoY); net income attributable $14.8M (+13%); diluted EPS $0.31 (+11%).
- Adjusted EBITDA $42.2M (+42% YoY); full-year 2024 guidance reaffirmed: revenue $1.65-1.85B, adj. EBITDA $165-185M.
- Completed largest acquisition (CFC) on Mar 31 and acquired PCCCV (~26K Medicaid members) on Mar 29.
- Organic membership growth 10% YTD; total lives ~1M; full-risk capitation expected ~60% of total capitation revenue as of Apr 1.
- Opened two new de novo clinics in Nevada in April.

## SEC filing metadata
- accession: 0001104659-24-058018
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465924058018/0001104659-24-058018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465924058018/tm2413600d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-058018
- JSON: https://secwatch.observer/filing/0001104659-24-058018.json
- Plain text: https://secwatch.observer/filing/0001104659-24-058018.txt

## Key facts
- Earnings Releases
  Astrana Health, Inc. updated its first quarter ended March 31, 2024 guidance (reaffirmed).
  - Period: first quarter ended March 31, 2024
  - Guidance: reaffirmed
  - Result: reported results
  source text: On May 7, 2024, Astrana Health, Inc. (the "Company") issued a press release announcing its financial results for the three months ended March 31, 2024. A copy of the press release and supplemental data is furnished with this Current Report on Form 8-K as Exhibit 99.1 and Exhibit 99.2, respectively, and incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465924058018/0001104659-24-058018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.